towards the choice of adequate comparator(s), selection of endpoints that are relevant to patients with a given disease … on the outcomes of a previously conducted questionnaire survey, four key areas, processes, uncertainty, comparator choice … and endpoint selection, were identifed. At the inaugural convention of the European Access Academy dedicated working …

drivers in HTAs today (scale 1, low to 5, high) were clinical trial design (mean 4.45), right endpoints (mean 4.40), and size … multitude of existing national assessments key methodological and process challenges need to be addressed. These include … approaches to address uncertainty in clinical development; comparator choice; consistency in approaching patient …

drivers in HTAs today (scale 1, low to 5, high) were clinical trial design (mean 4.45), right endpoints (mean 4.40), and size … multitude of existing national assessments key methodological and process challenges need to be addressed. These include … approaches to address uncertainty in clinical development; comparator choice; consistency in approaching patient …